Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carbogen for the treatment of febrile seizures
NCT01370044Phase 3Terminated
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Aug 2012
- Primary completion
- Jun 2015
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
A Phase 3 trial of carbogen in febrile seizure (FS), sponsored by Charité – Universitätsmedizin Berlin. Started Aug 2012; status: terminated.
02
Drugs
carbogen
03
Conditions
febrile seizure (FS)
Beyond the preview
Go deeper on NCT01370044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01370044.